Retatrutide is a weight management research compound currently in stock directly from a verified Chinese manufacturer. Every batch is HPLC-verified and shipped with a Certificate of Analysis (COA). Sourcing is direct — no intermediaries. Minimum order value is $300 USD. International shipping available.
Triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Among the most potent compounds currently under investigation in preclinical and clinical obesity research, with studies examining appetite signaling, energy expenditure, and metabolic parameters.
| Name | Strength | Pack Size | Purity | Availability | Price (USD) |
|---|---|---|---|---|---|
| Retatrutide | 5 mg | 10 vials | ≥98% | In Stock | $72.00 |
| Retatrutide | 10 mg | 10 vials | ≥98% | In Stock | $110.00 |
| Retatrutide | 15 mg | 10 vials | ≥98% | In Stock | $132.00 |
| Retatrutide | 20 mg | 10 vials | ≥98% | In Stock | $145.00 |
| Retatrutide | 30 mg | 10 vials | ≥98% | In Stock | $200.00 |
| Retatrutide | 60 mg | 10 vials | ≥98% | In Stock | $375.00 |
For laboratory research use only. Not for human or veterinary use. PeptidesFromChina.co is a B2B wholesale supplier operating under strict research-use-only terms. All products are sold exclusively for in vitro and preclinical research purposes.